RTW Investments, LP 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:13 am Purchase |
2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 7,423,970 9.800% |
1,808,583 (+32.21%) |
Filing |
| 2023-02-14 10:02 am Purchase |
2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 5,615,387 7.700% |
321,421 (+6.07%) |
Filing |
| 2022-02-14 08:00 am Purchase |
2021-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 5,293,966 7.500% |
325,757 (+6.56%) |
Filing |
| 2021-02-26 11:44 am Purchase |
2021-02-18 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 4,968,209 7.280% |
746,373 (+17.68%) |
Filing |
| 2021-02-12 09:34 am Purchase |
2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 4,221,836 6.190% |
389,356 (+10.16%) |
Filing |